Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
Doxorubicin (DOX) is a cytotoxic anthracycline antibiotic and one of the important chemotherapeutic agents for different types of cancers. DOX treatment is associated with adverse effects, particularly cardiac dysfunction. This study examined the cardioprotective effects of carvedilol (CAR) and/or r...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/9/2/159 |
id |
doaj-9561891a714b4a4abc9f4eebc8e30de9 |
---|---|
record_format |
Article |
spelling |
doaj-9561891a714b4a4abc9f4eebc8e30de92020-11-25T02:18:24ZengMDPI AGAntioxidants2076-39212020-02-019215910.3390/antiox9020159antiox9020159Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in RatsAbeer M. Alanazi0Laila Fadda1Ahlam Alhusaini2Rehab Ahmad3Iman H. Hasan4Ayman M. Mahmoud5Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaPhysiology Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef 62514, EgyptDoxorubicin (DOX) is a cytotoxic anthracycline antibiotic and one of the important chemotherapeutic agents for different types of cancers. DOX treatment is associated with adverse effects, particularly cardiac dysfunction. This study examined the cardioprotective effects of carvedilol (CAR) and/or resveratrol (RES) and liposomal RES (LIPO-RES) against DOX-induced cardiomyopathy, pointing to their modulatory effect on oxidative stress, inflammation, S100A1 and sarco/endoplasmic reticulum calcium ATPase2a (SERCA2a). Rats received CAR (30 mg/kg) and/or RES (20 mg/kg) or LIPO-RES (20 mg/kg) for 6 weeks and were challenged with DOX (2 mg/kg) twice per week from week 2 to week 6. DOX-administered rats exhibited a significant increase in serum creatine kinase-MB (CK-MB), troponin-I and lactate dehydrogenase (LDH) along with histological alterations, reflecting cardiac cell injury. Cardiac toll-like receptor 4 (TLR-4), inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)-α and interleukin (IL)-6 protein expression were up-regulated, and lipid peroxidation was increased in DOX-administered rats. Treatment with CAR, RES or LIPO-RES as well as their alternative combinations ameliorated all observed biochemical and histological alterations with the most potent effect exerted by CAR/LIPO-RES. All treatments increased cardiac antioxidants, and the expression of S100A1 and SERCA2a. In conclusion, the present study conferred new evidence on the protective effects of CAR and its combination with either RES or LIPO-RES on DOX-induced inflammation, oxidative stress and calcium dysregulation.https://www.mdpi.com/2076-3921/9/2/159doxorubicins100a1carvedilolphenolsoxidative stresscardiomyopathy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Abeer M. Alanazi Laila Fadda Ahlam Alhusaini Rehab Ahmad Iman H. Hasan Ayman M. Mahmoud |
spellingShingle |
Abeer M. Alanazi Laila Fadda Ahlam Alhusaini Rehab Ahmad Iman H. Hasan Ayman M. Mahmoud Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats Antioxidants doxorubicin s100a1 carvedilol phenols oxidative stress cardiomyopathy |
author_facet |
Abeer M. Alanazi Laila Fadda Ahlam Alhusaini Rehab Ahmad Iman H. Hasan Ayman M. Mahmoud |
author_sort |
Abeer M. Alanazi |
title |
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats |
title_short |
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats |
title_full |
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats |
title_fullStr |
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats |
title_full_unstemmed |
Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats |
title_sort |
liposomal resveratrol and/or carvedilol attenuate doxorubicin-induced cardiotoxicity by modulating inflammation, oxidative stress and s100a1 in rats |
publisher |
MDPI AG |
series |
Antioxidants |
issn |
2076-3921 |
publishDate |
2020-02-01 |
description |
Doxorubicin (DOX) is a cytotoxic anthracycline antibiotic and one of the important chemotherapeutic agents for different types of cancers. DOX treatment is associated with adverse effects, particularly cardiac dysfunction. This study examined the cardioprotective effects of carvedilol (CAR) and/or resveratrol (RES) and liposomal RES (LIPO-RES) against DOX-induced cardiomyopathy, pointing to their modulatory effect on oxidative stress, inflammation, S100A1 and sarco/endoplasmic reticulum calcium ATPase2a (SERCA2a). Rats received CAR (30 mg/kg) and/or RES (20 mg/kg) or LIPO-RES (20 mg/kg) for 6 weeks and were challenged with DOX (2 mg/kg) twice per week from week 2 to week 6. DOX-administered rats exhibited a significant increase in serum creatine kinase-MB (CK-MB), troponin-I and lactate dehydrogenase (LDH) along with histological alterations, reflecting cardiac cell injury. Cardiac toll-like receptor 4 (TLR-4), inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)-α and interleukin (IL)-6 protein expression were up-regulated, and lipid peroxidation was increased in DOX-administered rats. Treatment with CAR, RES or LIPO-RES as well as their alternative combinations ameliorated all observed biochemical and histological alterations with the most potent effect exerted by CAR/LIPO-RES. All treatments increased cardiac antioxidants, and the expression of S100A1 and SERCA2a. In conclusion, the present study conferred new evidence on the protective effects of CAR and its combination with either RES or LIPO-RES on DOX-induced inflammation, oxidative stress and calcium dysregulation. |
topic |
doxorubicin s100a1 carvedilol phenols oxidative stress cardiomyopathy |
url |
https://www.mdpi.com/2076-3921/9/2/159 |
work_keys_str_mv |
AT abeermalanazi liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats AT lailafadda liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats AT ahlamalhusaini liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats AT rehabahmad liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats AT imanhhasan liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats AT aymanmmahmoud liposomalresveratrolandorcarvedilolattenuatedoxorubicininducedcardiotoxicitybymodulatinginflammationoxidativestressands100a1inrats |
_version_ |
1724882395158544384 |